TipRanks
Pharma Mar SA (DE:PMRA)
FRANKFURT:PMRA
Germany Market
PMRA
Pharma Mar SA
RESEARCH TOOLSreports

Pharma Mar SA (PMRA) Stock News & Sentiment

0 Followers
PharmaMar Boosts Recurring Revenues on Zepzelca Growth Despite Lower One‑Off Income
Premium
Company Announcements
PharmaMar Boosts Recurring Revenues on Zepzelca Growth Despite Lower One‑Off Income
2d ago
Pharma Mar Names New Group CFO as Long-Serving Finance Chief Retires
Premium
Company Announcements
Pharma Mar Names New Group CFO as Long-Serving Finance Chief Retires
2d ago
Pharma Mar Continues September Share Buyback on Madrid Exchange
Premium
Company Announcements
Pharma Mar Continues September Share Buyback on Madrid Exchange
30d ago
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
Premium
Company Announcements
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
1M ago
Pharma Mar Details August Share Buyback Transactions on Madrid Bourse
Premium
Company Announcements
Pharma Mar Details August Share Buyback Transactions on Madrid Bourse
2M ago
Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
Premium
Company Announcements
Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
3M ago
Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen
Premium
Company Announcements
Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen
3M ago
More DE:PMRA News >

PMRA News on the Web

Pharma Mar Names New Group CFO as Long-Serving Finance Chief Retires
TipRanks News
Bullish
PharmaMar Boosts Recurring Revenues on Zepzelca Growth Despite Lower One‑Off Income
TipRanks News
Bullish
Pharma Mar Wins U.K. Approval for Zepzelca Combo in Small-Cell Lung Cancer
TipRanks News
Bullish
Pharma Mar (BME:PHM) Could Be 37% Below Fair Value Following Weak Half Year Earnings
Simply Wall St
Bullish
Analyst Estimates: Here's What Brokers Think Of Pharma Mar, S.A. (BME:PHM) After Its Half-Yearly Report
Simply Wall St
Neutral
PharmaMar’s Partner Merck Seeks Priority Approval in Japan for Zepzelca as First-Line SCLC Maintenance
TipRanks News
Bullish
Pharma Mar price target lowered to EUR 100 from EUR 120 at Chardan
TipRanks News
Neutral
EU clears PharmaMar’s Zepzelca combo for first‑line maintenance in aggressive lung cancer
TipRanks News
Bullish

News Score - Last 7 Days

Positive
DE:PMRA
Sector Average
Media Buzz
This Week2 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:PMRA’s Media Buzz Sentiment?
2 articles about DE:PMRA were published this week. In an average week, 0.75 articles are published.
    What is DE:PMRA’s weekly average amount of articles?
    In an average week, 0.75 articles about DE:PMRA are published.
      What is DE:PMRA’s News Sentiment?
      100% of articles about DE:PMRA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        GKOSGlaukos
        CNCCentene
        ASNDAscendis Pharma
        GILDGilead Sciences
        MRKMerck & Company
        Showing the stocks with the most bullish news sentiment over the past week